SHENGSHI MEDICAL TRAVEL
When the patient is a doctor: James’s CAR-T journey to China
An Australian pathologist facing relapsed myeloma looked closely at clinical suitability, treatment logistics and the cost of care abroad.
An Australian pathologist facing relapsed myeloma looked closely at clinical suitability, treatment logistics and the cost of care abroad.
This time, the report was his own
James, whose name has been changed, was a 56-year-old Australian pathologist with a seven-year history of multiple myeloma. After several lines of treatment, his disease had progressed again. His professional background helped him ask detailed questions about CAR-T, but it did not make the uncertainty easier for his family. He wanted to understand both the clinical pathway and whether a trip abroad was financially realistic.
Looking beyond a headline price
Cost was a major reason for looking overseas. But a price comparison is useful only when the product, eligibility, hospital stay, preparation, monitoring and possible additional care are understood. Shengshi helped organise James’s treatment history and records for hospital review, then coordinated a remote discussion. His questions included previous therapies, the proposed product, the cell collection and manufacturing process, risks and follow-up. A lower estimate alone was not a clinical reason to proceed.
A medical plan and a practical plan
Hospital charges and Shengshi’s coordination services were set out separately. Once arrangements were confirmed, our team helped with arrival, accommodation, appointments and interpreting. Collection, any bridging treatment, preparation for infusion and observation were managed by the hospital according to the clinical plan. Interpreting meant that his family could understand what was happening and know which questions to take back to the clinicians.
Waiting for the review
The observation period was emotionally difficult. CAR-T can involve serious complications, so clinical monitoring and access to urgent care mattered more than a busy travel itinerary. Later, James shared a follow-up result described as complete remission. That describes a response at a particular assessment; it does not mean a permanent cure or remove the need for ongoing follow-up. No timeline or result from his case can be promised to another patient.
The handover mattered too
Before James returned to Australia, the next steps included available hospital records, the agreed translations and follow-up arrangements for his home team. His story is about a doctor who became a patient and wanted a carefully explained path through an unfamiliar system. It is not evidence that a particular CAR-T product, hospital or price will be right for everybody. Current costs require an individual, itemised hospital quotation.
Read the complete Chinese original
一位澳洲医生，用不到十五万美金完成了 CAR-T：九十多万美金的账单，被改写
盛世医旅收到那封求助信时，发件人的身份栏写着 "Dr."。
写信的人叫詹姆斯（化名），56 岁，澳洲一名资深病理科医生，多发性骨髓瘤病史七年。一个每天在显微镜前解读别人诊断报告的人，这一次，轮到自己被疾病宣判。
他比谁都清楚 CAR-T，也比谁都清楚那张账单
七年里，詹姆斯先后尝试过多种治疗方案，病情反复，多线治疗后再次进展。作为医生，他太明白 CAR-T 意味着什么 —— 嵌合抗原受体 T 细胞疗法，抽取患者自身 T 细胞、体外改造后回输，精准杀伤肿瘤细胞，是复发难治血液肿瘤当下最有希望的方向之一。
他同样清楚的是价格。在澳洲，这样的 CAR-T 自费约六七百万人民币，折合约九十多万美元；即便走政府资助通道，也面临漫长的评估和排队。对一个已经烧了七年治疗费的普通家庭来说，这不是一道能咬牙扛过去的坎。
作为医生，他做了他能做的最严谨的功课
詹姆斯没有急着做决定。他查了全球 CAR-T 的可及情况，一条条核对：哪些国家有获批产品、哪些中心有成熟经验、技术是否可靠。结论让他自己也意外 —— 中国已有多款 CAR-T 产品获批上市，流程规范、经验成熟，而总费用约一百万人民币，折合不到十五万美元，只有澳洲的六分之一。
一名执业医生，最终决定把治疗放在中国。他说服家人，也说服自己：费用可以差出七倍，技术不能差出一分。
盛世医旅做的第一件事，不是报价
对接过程中，我们做的第一件事，不是报价，而是把詹姆斯七年的病历、历次治疗方案和影像资料逐项整理翻译，提交给合作医院做可行性评估。
随后是一场跨洋远程多学科会诊。屏幕这头，医生把适应症、治疗流程、预期效果和可能的不适拆开讲透；屏幕那头，詹姆斯用医生的语言追问每一个细节 —— 他问得越专业，反而越让人放心。会后，我们把费用构成和行程安排逐条列明，医院费用与服务费分开，哪些包含、哪些待定，没有一句含糊。
两周后，詹姆斯订了机票。
从采集到回输，全程有人在场
落地中国，接机、公寓、翻译、陪诊都已提前安排好。采集、桥接化疗、回输、观察，治疗链条上的每一个关键节点，都有专人陪同翻译。家属在异国他乡，深夜有担忧也能立刻找到人问个明白。
费用始终清晰 —— 出发前那张清单上的数字，就是全部，途中没有出现任何一笔临时支出。
"完全缓解。" 他说这两个词时，声音很轻
随访复查结果出来那天，詹姆斯在电话里对团队说了四个字："完全缓解。"
作为病理科医生，他比谁都清楚这两个字的分量。出院那天他说："同样打 CAR-T，在澳洲要九十多万美元，在这里不到十五万美元，效果还这么好。我用自己的专业查过、核实过，才敢做的决定 —— 事实证明，这个决定是对的。"
回国后，专属医生继续远程跟进他的用药与复查。这份来自中国的医疗支持，并未因距离而终止。
从九十多万美金到不到十五万美金，省下的是钱，换回的是希望。而一个医生患者的选择，或许比任何广告都更有分量 —— 这正是盛世医旅在做的事：把专业、规范、透明的跨国就医，送到每一个原本可能被费用和语言挡在门外的人面前。
Was this story helpful?
Like this articleReads are counted after time on the page, with analytics consent. Repeat visits from the same browser are limited to one per day.
Explore your own next step
More service stories
YOUR NEXT STEP
Start with a conversation.
Tell us your preferred language, travel dates and the support you need. We will explain the next steps before you book.